GSK PLC-SPON ADR (GSK) Institutional Ownership

GSK is currently held by 8 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $3.28B based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Dodge & Cox Stock Fund, which reported ownership valued at approximately $3.24B in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, Dodge & Cox Stock Fund's GSK position is now estimated to be worth approximately $3.05B, representing an estimated loss of -5.65% since the filing period.

Major shareholders tracked on this page include Dodge & Cox Stock Fund, Renaissance Technologies LLC, Kahn Brothers Group, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks institutional position trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward GSK PLC-SPON ADR (GSK).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20268$3,277,184,95859,380,050
Q4 20258$3,433,288,55270,009,962
Q3 20258$3,543,217,51982,094,938
Q2 20258$3,189,096,77483,049,395
Q1 20256$3,177,489,32482,020,891
Q4 20246$2,455,950,78272,618,297
Q3 20246$2,928,967,36371,647,930
Q2 20246$2,762,991,26571,766,007
Q1 20246$3,000,042,32871,771,593
Q4 20237$2,603,811,76273,021,782
Q3 20237$2,550,872,32473,277,970
Q2 20237$2,510,279,14673,587,811

Related GSK Institutional Insights: